Recent observations on new potential and established antidepressant drugs.
D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D000368:Aged; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001921:Brain / Q000378:metabolism; D001977:Brompheniramine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003704:Dementia / Q000188:drug therapy / Q000378:metabolism; D003866:Depressive Disorder / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008297:Male; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects; D011985:Receptors, Serotonin / Q000187:drug effects; D012106:Research; D012701:Serotonin / Q000378:metabolism; D012726:Sexual Behavior, Animal / Q000187:drug effects; D013329:Structure-Activity Relationship; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use; D015031:Zimeldine
D000928:Antidepressive Agents; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D013764:Tetrahydronaphthalenes; D012701:Serotonin; D015031:Zimeldine; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D001977:Brompheniramine